Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
The Egyptian Ministry of Antiquities is pleased to announce the launch of an egyptian – international Project using non-invasive and non-destructive surveying techniques for the scanning of Egyptian Pyramids under the title “ScanPyramids” project.
Just because a mystery is 4500 years old doesn’t mean it can’t be solved…” This could be the motto of the exceptional scientific mission launched October 25, 2015, under the authority of the Egyptian Ministry of Antiquities, initiated, designed and coordinated by the Faculty of Engineering of Cairo and the French HIP.Institute (Heritage, Innovation and Preservation). Radiographic muons, aka cosmic particles, infrared thermography, photogrammetry, scanner and 3D reconstruction: the most innovative technologies will be used by researchers of international renown and three major universities: the Faculty of Engineering of Cairo University, Université Laval of Quebec and Nagoya University of Japan. Their goal: to probe the heart of the largest pyramids of Egypt, without drilling the slightest opening.
Four millennia after their construction, these ancient giants are far from having yielded their secrets. The first mystery concerns their construction, especially Khufu, the last of the Seven Wonders of the Ancient World still existing: it is still impossible to describe with certainty how this stone monument, the largest ever built by humans, was erected.
The “ScanPyramids” project has already been approved by the permanent committee of the Ministry of Antiquities and has obtained all necessary permissions from concerned authorities. With a base of more than 5 hectares, its original height of almost 150 meters and a mass of 5 million tons, how was it possible to construct such a wonder in only 25 years?
To view the multimedia release go to:
http://www.multivu.com/players/uk/7671551-scanpyramids-project-launch-egyptian/
As an addition to the social responsibility project it started for sheltering street animals, the lucky address for shopping, n11.com, has now redesigned its delivery boxes, turning them into portable "homes" that can protect animals living on the streets from the harsh conditions of winter.
Contributing to the e-trade sector with its innovative activities, n11.com has completed the design work that it has been conducting in the last period, turning its delivery boxes into portable "homes" for street animals.
The special boxes were designed to especially endure cold weather conditions and were produced after approximately a year of Research and Development efforts. From now on, shoppers who order pet food on n11.com will be contributing to providing street dogs and cats with a warm home.
To view the multimedia release go to:
http://www.multivu.com/players/English/7664151-n11-com-boxes-homes-animals/
Today, premium men-s undergarment brand Tommy John launches the lightest men-s underwear ever created, aptly called Air. On the heels of their recently launched viral film campaign “The Big Adjustment”, Tommy John is debuting this collection of underwear and undershirts made from some of the most advanced fabric technology in the world.
After almost two years of product development, which included Founder and CEO Tom Patterson personally wear-testing, washing, drying, weighing and re-weighing the newest product line, Air is now available to the public. As part of the Light category of solution-based products, Air weighs-in at an average of two ounces. The ultra-lightweight and anti-microbial mesh fabric provides wearers maximum ventilation with unmatched durability and superior quick drying features.
“Air isn't only our greatest product achievement to date, but what we believe to be one of the greatest achievement ever for men's undergarments. We were able to create a product at less than half the weight of our competitors with Air,” says Tom Patterson, Founder & CEO of Tommy John. “We have never been so excited for a new collection.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7648931-tommy-john-the-big-adjustment/
Union Pacific Railroad this week launched a new campaign exclusively on social media, urging drivers and pedestrians to think about their personal safety first and wait at grade crossings. New videos depict different scenarios in which a jogger, young couple and father and son are stopped, waiting for a train to pass. When the arms lift, each proceeds safely toward a spectacular future.
“Our message is straightforward – Your Life is Worth the Wait,” said Scott Moore, Union Pacific senior vice president – Corporate Relations. “Union Pacific trains operate in more than 7,300 communities; too often our employees see drivers or pedestrians sneak around the gates. Even after applying the emergency brakes, it can take a mile for a train to stop; the risk is never worth it.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7508251-union-pacific-your-life-is-worth-the-wait/
After a highly successful inaugural event in 2014, Red Bull Straight Rhythm will return for a second consecutive year at Fairplex at Pomona, CA. An evolution of the sport of supercross, the event features head-to-head racing on an “unwound” track, where there are no turns, just a 1/2 mile-long straight track complete with 75 jumps and a 400-foot long whoops section, likely having riders spend more time airborne than on the ground. The event will be broadcast live and on demand beginning October 10th at 12:30pm PT on Red Bull TV as part of the Red Bull Signature Series, a collection of the most innovative and progressive events in action sports.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7627331-red-bull-signature-series/
Puja rituals are an integral part of Hindu culture. In order to stand out from numerous startups, currently competing with each other in the spiritual market domain, and to cater to millions of Hindus worldwide, WheresMyPandit has entered the field of mobile-commerce with the launch of its mobile application.
Built for Android users, WheresMyPandit expects an increase by three times for both inquiries and sales after the launch of the application. And, post the launch of the iOS application near to the Diwali season, it will multiply by nearly five times.
Not only can you book a pandit with a simple click through the application, but in the future, you can also chat or talk to the pandit to help you with various intricacies such as Muhurat timings and information about the puja on a real-time basis. A real-time tracking of the panditji will also be made available so you don't miss out on your muhurat timings while the pandit is on his way to conduct the puja.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7650651-mobile-commerce-with-wheresmypandit/
Boston Scientific (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) approval for the SYNERGY™ Bioabsorbable Polymer Drug-Eluting Stent System (BP-DES) for the treatment of coronary artery disease.
With this FDA approval, Boston Scientific will commence commercialization of the first and only BP-DES in the U.S. Notably, both the drug coating and the polymer – which modulates drug release – are fully absorbed shortly after drug elution is complete at three months.
The SYNERGY Stent provides synchronized drug and polymer absorption. It is designed to enable more rapid and complete arterial healing, and to thereby reduce the risk of complications associated with long-term polymer exposure compared to currently-used drug-eluting stents (DES) with permanent polymers.
To view the multimedia release go to:
http://www.multivu.com/players/English/7223456-boston-scientific-fda-approval-synergy/
Invuity, Inc. (NASDAQ:IVTY), an advanced medical technology company, announced today the launch of its Hidden ScarTM Surgery program designed to certify surgeons and establish Centers of Excellence at major cancer centers and hospitals across the country. This innovative program will train surgeons on advanced minimally invasive and minimal access surgical approaches that deliver optimal clinical and aesthetic outcomes for patients. As part of the company’s broader women’s health initiative, Invuity is hosting a Hidden Scar Breast Cancer Surgery training course in advance of the American College of Surgeons (ACS) Clinical Congress.
Invuity aims to transform the surgical treatment of breast cancer with this advanced surgical approach for nipple sparing mastectomies and lumpectomies (breast conserving surgery). Hidden Scar Breast Cancer Surgery expands surgical options for patients, offering superior cosmetic outcomes that can improve their psychological and emotional recovery and enhance quality of life after surgery.1
With growing demand for less invasive alternatives to breast cancer surgery, surgeons need to operate through smaller incisions with limited fields of vision. Invuity’s illumination technology allows surgeons to access and visualize the entire breast cavity through discrete incision locations, enabling surgeons to safely and effectively treat breast cancer while preserving the natural shape of the breast and thereby minimizing and hiding the scars.
To view the multimedia release go to:
http://www.multivu.com/players/English/7644051-invuity-hidden-scar-breast-cancer-surgery-program/
Fazlani Altius Business School (FABS) is an innovative management education model whereby students are pre-placed, before they even begin their MBA. This has been made possible through the unique Industry-Academia partnership model that runs as “of the corporate”, “by the corporate” and “for the corporate” concept.
Our Corporate partners engage right from the selection process, curriculum design, faculty for the program, extended internship design etc. This immersion is to ensure that the students are ready to hit the road and are productive from DAY 1 of joining their companies
This program is far more engaging even for students as questions like, what if we don’t get selected after MBA, what specialization to choose etc. are addressed even before they step in, thereby weeding whole lot of insecurity about future and careers. FABS ensures, students seamlessly move on from being a student, to an intern and finally a productive employee.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7632751-FABS-placement-before-admission/
